Surgiscreen Registration
NCT01589133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3109
Last updated 2013-05-30
Summary
The purpose of this study is to assess the consistency of the results of irregular antibody screening with Surgiscreen （investigational reagent) and Serascan Diana 3 (control reagent), and the consistency of the results of irregular antibody screening with investigational reagent on serum and plasma from same patients.
Conditions
- Irregular Antibody Screening
Sponsors & Collaborators
-
Johnson & Johnson Medical, China
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- China
Study Locations
More Related Trials
-
Role of Serum Regucalcin in Diagnosis of Hepatocellular Carcinoma
NCT03206866 ·Status: UNKNOWN
-
Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer
NCT05336058 ·Status: COMPLETED
-
Pan-canceR Early DetectIon projeCT (PREDICT)
NCT04817306 ·Status: UNKNOWN
-
Role of Genomic Imprinting in Cancer Diagnosis
NCT03882684 ·Status: UNKNOWN
-
A Screening Study Targeting Tumor-specific Antigens
NCT05158621 ·Status: COMPLETED
-
A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma
NCT06658587 ·Status: NOT_YET_RECRUITING
-
AssesSment of Early deteCtion basEd oN liquiD Biopsy in Intracranial Tumors
NCT05679089 ·Status: UNKNOWN
-
IDENTIFY Study: Natural History of Maternal Neoplasia
NCT04049604 ·Status: RECRUITING ·Phase: NA
-
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
NCT04085900 ·Status: RECRUITING
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT00026884 ·Status: RECRUITING
-
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
NCT00806650 ·Status: COMPLETED
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types
NCT03869814 ·Status: RECRUITING
-
Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma
NCT03692533 ·Status: UNKNOWN ·Phase: NA
-
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 ·Status: RECRUITING
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
NCT05685524 ·Status: UNKNOWN
-
Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT
NCT04822792 ·Status: UNKNOWN
-
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
NCT03596593 ·Status: UNKNOWN ·Phase: NA
-
Caris Biorepository Research Protocol
NCT01499394 ·Status: RECRUITING
-
Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors
NCT05831631 ·Status: RECRUITING
-
Biomolecular Analysis for Predicting Response to Regorafenib
NCT05759195 ·Status: COMPLETED ·Phase: NA
-
Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue
NCT00581698 ·Status: COMPLETED
-
Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers
NCT05160337 ·Status: RECRUITING ·Phase: NA
-
SCRI Tissue Testing Registry
NCT00965861 ·Status: TERMINATED